KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Stereotaxis (STXS) over the last 17 years, with Q3 2025 value amounting to $10.5 million.

  • Stereotaxis' Cash & Equivalents fell 147.24% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year decrease of 147.24%. This contributed to the annual value of $12.2 million for FY2024, which is 4058.46% down from last year.
  • As of Q3 2025, Stereotaxis' Cash & Equivalents stood at $10.5 million, which was down 147.24% from $7.0 million recorded in Q2 2025.
  • Over the past 5 years, Stereotaxis' Cash & Equivalents peaked at $43.9 million during Q2 2021, and registered a low of $6.8 million during Q1 2023.
  • Over the past 5 years, Stereotaxis' median Cash & Equivalents value was $20.6 million (recorded in 2023), while the average stood at $23.3 million.
  • As far as peak fluctuations go, Stereotaxis' Cash & Equivalents crashed by 8165.59% in 2023, and later surged by 16991.12% in 2024.
  • Quarter analysis of 5 years shows Stereotaxis' Cash & Equivalents stood at $40.1 million in 2021, then crashed by 78.61% to $8.6 million in 2022, then surged by 139.48% to $20.6 million in 2023, then tumbled by 40.58% to $12.2 million in 2024, then decreased by 14.01% to $10.5 million in 2025.
  • Its Cash & Equivalents stands at $10.5 million for Q3 2025, versus $7.0 million for Q2 2025 and $10.7 million for Q1 2025.